Structure modeling of the chemokine receptor CCR5: Implications for ligand binding and selectivity

被引:71
|
作者
Paterlini, MG
机构
[1] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S0006-3495(02)75307-1
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The G-protein coupled receptor CCR5 is the main co-receptor for macrophage-tropic HIV-1 strains. I have built a structural model of the chemokine receptor CCR5 and used it to explain the binding and selectivity of the antagonist TAK779. Models of the extracellular (EC) domains of CCR5 have been constructed and used to rationalize current biological data on the binding of HIV-1 and chemokines. Residues spanning the transmembrane region of CCR5 have been modeled after rhodopsin, and their functional significance examined using the evolutionary trace method. The receptor cavity shares six residues with CC-chemokine receptors CCR1 through CCR4, while seven residues are unique to CCR5. The contribution of these residues to ligand binding and selectivity is tested by molecular docking simulations of TAK779 to CCR1, CCR2, and CCR5. TAK779 binds to CCR5 in the cavity formed by helices 1, 2, 3, and 7 with additional interactions with helices 5 and 6. TAK779 did not dock to either CCR1 or CCR2. The results are consistent with current site-directed mutagenesis data and with the observed selectivity of TAK779 for CCR5 over CCR1 and CCR2. The specific residues responsible for the observed selectivity are identified. The four EC regions of CCR5 have been modeled using constrained simulated annealing simulations. Applied dihedral angle constraints are representative of the secondary structure propensities of these regions. Tertiary interactions, in the form of distance constraints, are generated from available epitope mapping data. Analysis of the 250 simulated structures provides new insights to the design of experiments aimed at determining residue-residue contacts across the EC domains and for mapping CC-chemokines on the surface of the EC domains.
引用
收藏
页码:3012 / 3031
页数:20
相关论文
共 50 条
  • [1] Modeling of the chemokine receptor CCR5: Implications for ligand binding.
    Paterlini, MG
    Portoghese, PS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U24 - U24
  • [2] Cholesterol impacts chemokine CCR5 receptor ligand-binding activity
    Calmet, Pierre
    Cullin, Christophe
    Cortes, Sandra
    Vang, Maylou
    Caudy, Nada
    Baccouch, Rim
    Dessolin, Jean
    Maamar, Nada Taib
    Lecomte, Sophie
    Tillier, Bruno
    Alves, Isabel D.
    FEBS JOURNAL, 2020, 287 (11) : 2367 - 2385
  • [3] The chemokine receptor, CCR5
    Mueller, A
    Strange, PG
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (01): : 35 - 38
  • [4] Isolation and structure of antagonists of chemokine receptor (CCR5)
    Jayasuriya, H
    Herath, KB
    Ondeyka, JG
    Polishook, JD
    Bills, GF
    Dombrowski, AW
    Springer, MS
    Siciliano, S
    Malkowitz, L
    Sanchez, M
    Guan, ZQ
    Tiwari, S
    Stevenson, DW
    Borris, RP
    Singh, SB
    JOURNAL OF NATURAL PRODUCTS, 2004, 67 (06): : 1036 - 1038
  • [5] Chemokine receptor CCR5: insights into structure, function, and regulation
    Oppermann, M
    CELLULAR SIGNALLING, 2004, 16 (11) : 1201 - 1210
  • [6] Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor
    Saita, Yuji
    Kondo, Mitsuhiro
    Shimizu, Yasuaki
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (12) : 1528 - 1534
  • [7] Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)
    Garcia-Perez, Javier
    Rueda, Patricia
    Alcami, Jose
    Rognan, Didier
    Arenzana-Seisdedos, Fernando
    Lagane, Bernard
    Kellenberger, Esther
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (38) : 33409 - 33421
  • [8] Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions
    Nakata, Hirotomo
    Kruhlak, Michael
    Kamata, Wakako
    Ogata-Aoki, Hiromi
    Li, Jianfeng
    Maeda, Kenji
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    ANTIVIRAL THERAPY, 2010, 15 (03) : 321 - 331
  • [9] Characterization of the CCR5 chemokine receptor gene
    Thomas, JC
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2004, 32 (03) : 191 - 195
  • [10] Pharmacological characterization of the chemokine receptor, CCR5
    Mueller, A
    Mahmoud, NG
    Goedecke, MC
    McKeating, JA
    Strange, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (04) : 1033 - 1043